卫光生物
(002880)
| 流通市值：65.50亿 | | | 总市值：65.50亿 |
| 流通股本：2.27亿 | | | 总股本：2.27亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 226,302,459.95 | 1,048,502,589.77 | 735,431,674 | 457,166,651.7 |
| 营业收入 | 226,302,459.95 | 1,048,502,589.77 | 735,431,674 | 457,166,651.7 |
| 二、营业总成本 | 171,996,950.01 | 826,102,717.53 | 565,204,037.72 | 342,532,074.76 |
| 营业成本 | 128,362,165.11 | 615,258,881.42 | 419,912,589.06 | 264,447,948.76 |
| 税金及附加 | 1,782,190.54 | 7,794,390.92 | 4,693,416.3 | 3,223,441.39 |
| 销售费用 | 5,219,381.12 | 40,884,889.51 | 24,994,582.25 | 16,821,184.48 |
| 管理费用 | 19,969,094.09 | 86,056,192.35 | 56,909,156.25 | 37,673,279.87 |
| 研发费用 | 12,223,999.54 | 63,616,220.29 | 50,435,388.95 | 18,783,841.17 |
| 财务费用 | 4,440,119.61 | 12,492,143.04 | 8,258,904.91 | 1,582,379.09 |
| 其中:利息费用 | 4,583,750.59 | 15,180,683.8 | 9,659,562.17 | 2,362,435.04 |
| 其中:利息收入 | 368,471.81 | 2,822,371.44 | 2,159,491.18 | 1,307,040.82 |
| 加:公允价值变动收益 | - | 2,226,973.85 | - | - |
| 加:投资收益 | - | 5,205,734.81 | - | - |
| 信用减值损失(新) | -503,396.46 | 3,226,404.69 | 2,913,528.16 | 3,416,479.31 |
| 其他收益 | 1,577,431.05 | 14,249,689.01 | 5,493,723.56 | 3,580,597.03 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 55,379,544.53 | 247,308,674.6 | 178,634,888 | 121,631,653.28 |
| 加:营业外收入 | 148,424.41 | 331,094.68 | 638,759.22 | 36,759.22 |
| 减:营业外支出 | 187,315.24 | 2,185,156.75 | 2,020,994.61 | 1,796,005.85 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 55,340,653.7 | 245,454,612.53 | 177,252,652.61 | 119,872,406.65 |
| 减:所得税费用 | 8,546,869.66 | 27,909,976.69 | 25,904,244.01 | 18,984,411.33 |
| 六、净利润 | 46,793,784.04 | 217,544,635.84 | 151,348,408.6 | 100,887,995.32 |
| 持续经营净利润 | 46,793,784.04 | 217,544,635.84 | 151,348,408.6 | 100,887,995.32 |
| 归属于母公司股东的净利润 | 46,831,857.32 | 218,651,341.25 | 151,241,017.19 | 101,025,551.22 |
| 少数股东损益 | -38,073.28 | -1,106,705.41 | 107,391.41 | -137,555.9 |
| (一)基本每股收益 | 0.21 | 0.96 | 0.67 | 0.45 |
| (二)稀释每股收益 | 0.21 | 0.96 | 0.67 | 0.45 |
| 九、综合收益总额 | 46,793,784.04 | 217,544,635.84 | 151,348,408.6 | 100,887,995.32 |
| 归属于母公司股东的综合收益总额 | 46,831,857.32 | 218,651,341.25 | 151,241,017.19 | 101,025,551.22 |
| 归属于少数股东的综合收益总额 | -38,073.28 | -1,106,705.41 | 107,391.41 | -137,555.9 |
| 公告日期 | 2024-04-26 | 2024-04-26 | 2023-10-26 | 2023-08-25 |
| 审计意见(境内) | | 标准无保留意见 | | |